Clinical Trial Update: Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating retifanlimab in combination with gemcitabine and docetaxel for advanced soft tissue sarcoma; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)
• Retifanlimab (retifanlimab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Soft Tissue Sarcoma, Sarcoma,Soft Tissue | Phase 1, Phase 2 | Status: RECRUITING